NCT03996382

Brief Summary

Wild-type transthyretin cardiac amyloidosis is an underdiagnosed depository disease in which fibril monomers of misfolded amyloid protein accumulates in various tissues, including the heart, and cause tissue dysfunction. Before onset of cardiac symptoms, many patients will have undergone surgery for idiopathic carpal tunnel syndrome since the protein also deposits in the transversal carpal ligament of the hand. This study investigates patients previously operated for idiopathic carpal tunnel syndrome to determine if they display signs and symptoms of cardiac amyloidosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 17, 2019

Completed
Same day until next milestone

Study Start

First participant enrolled

June 17, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 24, 2019

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

October 8, 2021

Status Verified

October 1, 2021

Enrollment Period

1.5 years

First QC Date

June 17, 2019

Last Update Submit

October 1, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevalence of cardiac amyloidosis.

    The prevalence of cardiac amyloidosis among patients previously operated for ipiopathic carpal tunnel syndrome.

    Through study completion, an average of 2 years.

Study Arms (1)

Suspicion of cardiac amyloidosis

OTHER

Patients who display signs of cardiac amyloidosis will be referred for further diagnosis.

Diagnostic Test: DPD Scintigraphy

Interventions

DPD ScintigraphyDIAGNOSTIC_TEST

Confirms/Refutes diagnosis of cardiac amyloidosis.

Suspicion of cardiac amyloidosis

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients above sixty years of age previously operated for idiopathic carpal tunnel syndrome within the Region of Central Denmark (Region Midtjylland) the last five years.
  • Informed written and verbal consent

You may not qualify if:

  • Operation by different indication such as
  • Fracture
  • Ganglion
  • Tumors
  • Osteophytes
  • Rheumatoid Arthritis
  • Persistent medial artery
  • Metabolic causes
  • Alcoholism
  • Hyperthyroidism
  • Myxedema
  • Hereditary Cardiac Amyloidosis
  • Known WT ATTR
  • AL Amyloidosis
  • Myelomatosis
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Heart Disease

Aarhus, 8200, Denmark

Location

MeSH Terms

Conditions

Amyloid Neuropathies, FamilialCarpal Tunnel Syndrome

Condition Hierarchy (Ancestors)

Heredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesNervous System DiseasesAmyloid NeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesAmyloidosis, FamilialMetabolism, Inborn ErrorsMetabolic DiseasesNutritional and Metabolic DiseasesAmyloidosisProteostasis DeficienciesMedian NeuropathyMononeuropathiesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 17, 2019

First Posted

June 24, 2019

Study Start

June 17, 2019

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

October 8, 2021

Record last verified: 2021-10

Locations